SCHEMBL3441237

SCHEMBL3441237

CCCCn1c(=O)c(-c2ccccc2)nc2ccccc21.CCn1c(=O)c(Cc2ccc(Cl)cc2)nc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 5/20 0.53
HTT P42858 1/20 0.53
CFTR P13569 5/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
HPGD P15428 2/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PDE4D Q08499 2/20 0.48
MLNR O43193 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
ADRA1A P35348 1/20 0.48
PTGS2 P35354 1/20 0.48
HRH1 P35367 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982260 0.85 CFTR (0.55) KDM4EALDH1A1HTTCFTRNPC1
SCHEMBL985091 0.85 MAPK1 (0.66) KDM4EALDH1A1RAB9AHPGDLMNA
SCHEMBL981153 0.83 CFTR (0.64) KDM4EALDH1A1HTTCFTRNPC1
SCHEMBL979635 0.81 CFTR (0.64) KDM4EALDH1A1CFTRHPGDLMNA
SCHEMBL982499 0.77 MAPK1 (0.75) KDM4EALDH1A1HPGDLMNAMAPK1
SCHEMBL979729 0.75 MAPK1 (0.68) KDM4EALDH1A1HTTNPC1RAB9A
SCHEMBL981905 0.74 KDM4E (0.55) KDM4EALDH1A1HTTCFTRNPC1
SCHEMBL980773 0.74 CFTR (0.64) KDM4EALDH1A1HTTCFTRHPGD
SCHEMBL981894 0.74 KDM4E (0.74) KDM4EALDH1A1HTTNPC1RAB9A
SCHEMBL981613 0.73 CFTR (0.67) KDM4EALDH1A1CFTRHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247580-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-10 EP disclosed
WO-2009109258-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-11 WO disclosed